James O. Armitage's most recent trade in Cardiff Oncology Inc was a trade of 40,565 Stock Options done . Disclosure was reported to the exchange on June 26, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Cardiff Oncology Inc | James O. Armitage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jun 2025 | 40,565 | 187,539 | - | - | Stock Options | |
Cardiff Oncology Inc | James O. Armitage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Jun 2024 | 29,700 | 146,974 | - | - | Stock Options | |
Cardiff Oncology Inc | James O. Armitage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2023 | 27,700 | 117,274 | - | - | Stock Options | |
Cardiff Oncology Inc | James O. Armitage | Director | Purchase of securities on an exchange or from another person at price $ 1.56 per share. | 16 Sep 2022 | 13,000 | 13,000 (0%) | 0% | 1.6 | 20,233 | Common Stock |
Cardiff Oncology Inc | James O. Armitage | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Mar 2022 | 26,800 | 89,574 | - | - | Stock Options | |
Cardiff Oncology Inc | James O. Armitage | Director | Purchase of securities on an exchange or from another person at price $ 10.82 per share. | 19 Mar 2021 | 4,000 | 14,490 (0%) | 0% | 10.8 | 43,271 | Common Stock |